At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 68 enrolled
Drug / intervention
Triamcinolone Acetonidedrug
Likely dose
Triamcinolone Acetonide 1 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Symptom Clusters in Children With Exacerbation-prone Asthma
In Brief
A Phase 2 clinical trial evaluating Triamcinolone Acetonide for Asthma in Children. Completed, enrolled 68 participants across 2 sites.
Detailed Summary
Pediatric participants with exacerbation-prone asthma will receive an intramuscular injection of triamcinolone acetonide and will be followed for 48 weeks. The study visit 2 weeks after the injection will assess the response to the study medication, while the remaining study visits will examine the temporal stability of the symptom clusters.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma in Children
CountriesUnited States
CollaboratorsNational Institute of Nursing Research (NINR)
Timeline
Phase 2CompletedFinished
2020202120222023202420252026
First PostedJun 2019
Enrollment StartNov 2019
Primary CompletionJan 2025
Study CompletionDec 2025
TodayJul 2026
First PostedJun 28, 2019
Enrollment StartNov 13, 2019
Primary CompletionJan 16, 2025
Study CompletionDec 24, 2025
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 7.0 years ago
Interventions
Triamcinolone Acetonidedrug
An intramuscular injection of triamcinolone acetonide (1 mg/kg, up to 40 mg maximum) is administered deep in the gluteal muscle by a trained registered nurse.